Previous studies in inflammatory bowel disease have shown that butyrate may contribute to the restoration of the tight junction barrier by affecting the expression of Claudin‐2, Occludin, Cingulin, ZO‐1, and ZO‐2 [reviewed by Ploger et al. (2012)]. The gene discussed is TJP2; the disease is inflammatory bowel disease.